A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days
Wall, James G, Burris, Howard A, Von Hoff, Daniel D, Rodriguez, Gladys, Kneuper-Hall, Rayna, Shaffer, Don, OʼRourke, Timothy, Brown, Thomas, Weiss, Geoffrey, Clark, Gary, McVea, Shirley, Johnson, RandVolume:
3
Journal:
Anti-Cancer Drugs
DOI:
10.1097/00001813-199208000-00004
Date:
August, 1992
Fichier:
PDF, 659 KB
1992
File converter
Plus de résultats de recherche
More benefits 
